Navigation Links
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
Date:6/30/2008

al benefit of an add-on therapy in PAH patients who are already receiving an approved background therapy. The study population consisted of 235 patients who were optimized on an approved oral therapy for PAH, either bosentan (Tracleer(R)), an endothelin receptor antagonist, or sildenafil (Revatio(R)), a phosphodiesterase-5 inhibitor. The majority of patients were New York Heart Association (NYHA) Class III (~98%) of varied etiologies, including idiopathic or familial PAH (~60%), collagen vascular disease associated PAH (~30%), and PAH associated with HIV, anorexigens or other associated conditions (~10%).

The primary efficacy endpoint of the TRIUMPH-1 clinical trial was the change in six-minute walk (6MW) distance at 12 weeks measured at peak exposure, defined by the trial protocol as 10-60 minutes after administration of ITRE relative to baseline. Analysis of the TRIUMPH-1 clinical trial results confirmed an improvement in median 6MW distance of approximately 20 meters (p<0.0005 at peak exposure, Hodges-Lehmann estimate and non-parametric analysis of covariance in accordance with the trial's pre-specified statistical analysis plan), in patients receiving ITRE as compared to patients receiving only background therapy. In addition, the 6MW distance at week 12 relative to baseline at trough exposure was also significantly improved, with an estimated treatment effect of approximately 14 meters (p<0.007). Secondary endpoints related to quality of life and change in NT pro-BNP, a plasma biomarker of cardiac function, were also significantly improved in the ITRE group as compared to the group receiving only background therapy (p<0.05). Other secondary efficacy measures, including change in Borg Dyspnea Score (shortness of breath test), NYHA functional class, signs and symptoms score, and time to clinical worsening, were not significantly different between the ITRE and background therapy only groups. Safety findings were typically those associated with the well-know
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
2. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
3. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
4. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
5. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
6. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
7. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
8. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
9. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
10. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
11. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , 7. Juli 2015 BioClinica®, ... für klinische Studien, gab heute bekannt, dass es ... Unternehmen bei Gewinnung und Erhalt von Patienten übernommen ... MediciGlobal , Ltd. und Access to Patients, ... einen Dienst zum Auffinden von Patienten, die für ...
(Date:7/7/2015)... , July 7, 2015 /PRNewswire/ -- Mindray Medical ... leading developer, manufacturer and marketer of medical devices ... the remaining stake in Wuhan Dragonbio Surgical Implant ... Dragonbio is a domestic medical orthopedic-product ... other surgical products. Prior to today,s announcement, Mindray ...
(Date:7/7/2015)... , July 7, 2015 Oasmia ... drugs within human and veterinary oncology, has filed a ... Exchange Commission, in connection with the proposed public offering ... Market. The number of American Depositary Shares, representing ordinary ... the offering have not yet been determined. An Investor ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2
(Date:7/7/2015)... ... July 07, 2015 , ... ... Cambridge Consultants that discussed how innovation and technology would be the “key factors” ... to address issues of accessibility and affordability, especially in emerging and growing markets. ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Today, the physicians ... major medical facilities in Orange and San Bernardino counties, released a series of tips ... particularly hazardous time of year for children, who spend more unsupervised time outdoors. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Leading healthcare consulting ... Warden as Senior Vice President, heading the firm’s Healthcare Advisory Services division. , ... solutions to healthcare providers’ needs in ways that strengthen their position in the ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Difass USA, ... can help pass those long, stressful days at work is knowing that there is ... as laid back and stress free as imagined. Planning for a vacation can be ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... firms have merged to form Camber Collective. Camber Collective provides strategic advisory ... combines SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in customer ...
Breaking Medicine News(10 mins):Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2
... Awareness, Education about Bone Disease, HARRISBURG, ... the bone-weakening disease osteoporosis, the Pennsylvania,Commission for ... Association,and Pennsylvania Dairy Promotion Program to launch ... Cameron, Clinton, Juniata,Perry, Sullivan, and Tioga counties., ...
... Public Relations,has been retained by Diagnostic Centers of America ... a revolutionary breakthrough in cardiac,and diagnostic medical imaging, enabling ... time than it takes to beat and without the ... following the installation of the new SOMATOM,Definition dual source ...
... For most people, the significant,downtime involved in undergoing ... signs of aging skin is not realistic given ... minimally invasive,laser skin resurfacing technologies are delivering noticeable ... without spending weeks under,wraps, as is common with ...
... activities to improve balance , , SUNDAY, Feb. 3 (HealthDay News) ... seniors over age 65, and almost one in two over ... in some cases, leading to serious disability or even death. ... reduce their risk of falls are expected to be discussed ...
... poor thwart reaching 2010 benchmark , , SATURDAY, Feb. 2 ... will fall far short of its benchmark goals toward ... and Nutritional Examination Survey data. , Researchers found that ... U.S. population in 1999-2000 was 4.2 percent. This does ...
... iVillage Take Women,s Pulse on Key,Issues at ,How She ... AARP, which is,marking its 50th Anniversary, and iVillage, the ... of engaged, diverse women for the,groundbreaking "How She Will ... and providing a real-time pulse check of the issues ...
Cached Medicine News:Health News:PA Commission for Women Announces 'Shocking Pink' Osteoporosis Campaign in Rural PA 2Health News:Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With World's Most Advanced Cardiac Scanner 2Health News:Keep Father Time From Marching On: New Laser Treatments Offer Gentle and Effective Skin Resurfacing in a Flash 2Health News:Keep Father Time From Marching On: New Laser Treatments Offer Gentle and Effective Skin Resurfacing in a Flash 3Health News:Keep Father Time From Marching On: New Laser Treatments Offer Gentle and Effective Skin Resurfacing in a Flash 4Health News:Toll-Free Hotline to Help Seniors Avoid Falls 2Health News:U.S. Unlikely to Meet Target for TB Elimination 2Health News:Women Believe Economy Is Top Issue in 2008 Election 2Health News:Women Believe Economy Is Top Issue in 2008 Election 3
The CGPL capsulotomy contact glass was designed by Riquin, Fankhauser et al. for the dissection of opacified posterior lens capsules and membranes in the pupillary and retropupillary space with the Y...
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
Medicine Products: